General Outpatient Clinic Public-Private Partnership Programme (GOPC PPP)
Patients fulfilling pre-defined clinical criteria and programme requirements and who have been attending HA Outpatient Clinic for at least 12 months will be invited to join the Programme to receive primary care service from the private sector.


Issue 41 - Updates on the List of Specified Drugs


Dear Doctors,

Thank you for your participation and continual support to the Programme. We are pleased to advise you on the latest update of the List of Specified Drugs.

  1. Expansion of Programme Drug List for Co-care (O&T)

    With the newly launched Co-care Service Model riding on the existing programme, the PPP patient invitation pool had been extended to eligible patients who are attending Medicine (MED) or Orthopaedics & Traumatology (O&T) SOPCs in designated clusters, fulfilling the pre-defined clinical criteria and are in stable conditions. Eligible patients would be invited by batches from 3Q 2021 onwards to join the programme under the Co-care Service Model.

    We are pleased to inform you that 11 new drugs would be added to the “List of Specified Drugs” for participating patients under Co-care (O&T) programme, starting from 17 December 2021. You can refer to the Appendix for details. Please be advised that the newly added drug items only applied for participating patients referred by SOPC(O&T) under the Co-care (O&T) programme. The ordering of the 11 new drugs would be opened to Participating Service Providers with enrolled Co-care (O&T) patients starting from 17 December 2021.

    Regarding the latest updates on the Co-care Service Model, an interactive online information session had been conducted for our Participating Service Providers and professional associations on 24 November 2021 afternoon. Please stay tuned for our Co-care Service Model through the e-Bulletin and webinars in understanding more about the programme and clinical management tips upon extension of the patient invitation scope.

  2. Update on Medication Pull-down List Display

    In view of the expansion of disease types to be covered under the Programme, the pull-down list display of standard drug items will no longer be categorized by clinical conditions. Instead, it will be displayed in alphabetical order.

    You can always make good use of the ‘Copy Drug(s)’ and ‘Smart search’ functions to facilitate the input of medication records. Please be reminded to take extra caution when entering or copying prescription records on the IT platform.

    issue 41

  3. Resumption of the supply of Potassium Chloride SR Tablet

    The supply of the Potassium Chloride SR Tablet 600mg, which was temporary suspended due to supply interruption since December 2017, will soon be resumed. You may access the drug ordering platform on eHRSS to check the updated balance, starting from 26 December 2021.

    Please be reminded that the orderable quantities of Programme Drugs are varied by the number of enrolled patients prescribed with the drug item. In this regard, timely input of prescription records in the GOPC PPP Profile is essential for you to be able to see the most updated quantity of drug that could be ordered.

    Should you have any enquiries regarding the GOPC PPP, please feel free to contact us at or via the Programme hotline 2300 7300 (after selecting language, press 5 to speak directly with our hotline staff). Thank you.

Yours faithfully,
GOPC PPP Programme Office
Hospital Authority



List of Specified Drugs


Clinical Indication Drugs Applicable to Designated Outpatient Clinic Referred Patient
Anti-hypertensive Lisinopril Tablet 5mg (ACEI & ARB) GOPC / SOPC (MED)
Lisinopril Tablet 10mg
Lisinopril Tablet 20mg
Losartan Potassium Tablet 50mg
Perindopril Tertbutylamine Tablet 4mg
Atenolol Tablet 50mg (Beta Blockers)
Atenolol Tablet 100mg
Metoprolol Tartrate Tablet 50mg
Metoprolol Tartrate Tablet 100mg
Propranolol HCl Tablet 10mg
Amlodipine (Besylate) Tablet 5mg (CCB)
Amlodipine (Besylate) Tablet 10mg
Felodipine Extended Release Tablet 5mg
Felodipine Extended Release Tablet 10mg
Dyazide (or Equiv) Tablet (Diuretics)
Indapamide Tablet 2.5mg
Moduretic (or Equiv) Tablet
Supplementary to Anti-hypertensive Aspirin Tablet 80mg GOPC / SOPC (MED)
Potassium Chloride SR Tablet 600mg
Prazosin (HCl) Tablet 1mg
Prazosin (HCl) Tablet 2mg
Terazosin HCl Tablet 2mg
Lipid-regulating Atorvastatin (Calcium) Tablet 10mg GOPC / SOPC (MED)
Atorvastatin (Calcium) Tablet 20mg
Simvastatin Tablet 10mg
Simvastatin Tablet 20mg
Anti-diabetic Gliclazide Tablet 80mg GOPC / SOPC (MED)
Metformin HCl Tablet 500mg
Drugs for bone and joint pain Alendronate Sodium Tablet (70mg Alendronic Acid) SOPC (O&T)
Calcium (Carbonate) + Vitamin D Chew Tablet 1000mg Ca + 800 IU
Diclofenac Sodium Slow Release Tablet 100mg
Heparinoid Cream 14g
Ibandronic Acid Tablet 150mg
Methyl Salicylate Compound Ointment 20g
Paracetamol Tablet 500mg
Pregabalin Capsule 25mg
Pregabalin Capsule 75mg
Pregabalin Capsule 150mg
Tramadol HCl Capsule 50mg
Antibiotics Augmentin (or Equiv) Tablet 375mg All Programme Designated Outpatient Clinics
Ciprofloxacin (HCl) Tablet 250mg
Clarithromycin Tablet 250mg
Drugs for associated health problems Aluminium / Magnesium Hydroxide and Simethicone Tablet All Programme Designated Outpatient Clinics
Ammonia and Ipecacuanha Mixture*
Chlorpheniramine Maleate Tablet 4mg
Diclofenac Sodium Tablet 25mg
Famotidine Tablet 20mg
Famotidine Tablet 40mg
Ibuprofen Tablet 200mg
Loratadine Tablet 10mg
Naproxen Tablet 250mg
Senna Tablet 7.5mg

* 120ml/Bottle